USD10
Actions NBP
À propos de NovaBridge BiosciencesNovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
USD10
Actions NBP
À propos de NovaBridge BiosciencesNovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
Statistiques
FENÊTRE DE TRADING
Fermé
OUVRE À
Données insuffisantes
Capitalisation boursière
296,30 M $US
PRIX D'OUVERTURE
2,75 $US
BAS (1 an)
0,595 $US
ÉLEVÉ (1 an)
6,79 $US
BAS (24 h)
2,53 $US
ÉLEVÉ (24 h)
2,76 $US
Volume (24 h)
504,27 k $US
2,37 %
Historique des prix
Time | Price | Change |
|---|---|---|
Aujourd'hui | 2,75 $US | |
1 jour | 2,56 $US |